Biotechnology · Healthcare
CEO
Equibles does not estimate personal net worth.
Get an email with a short summary when Mineralys Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get MLYS alertsJohn Conkelton is recorded as CEO at Mineralys Therapeutics, Inc. (MLYS). John Conkelton has spoken on 1 investor event across 1 company, most recently for Mineralys Therapeutics, Inc. on November 12, 2026. Mineralys Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Mineralys Therapeutics, Inc. includes Jon Congleton (CEO and Board Member), Glenn P. Sblendorio (Chairman), Alexander Gold (Board Member) and 6 others.
“Yeah, happy to do it, and good to see you, Annabelle, and thank you again to the Stiefel team. Always enjoy the conference and the opportunity to talk about mineralis.”
Biotechnology · Healthcare
CEO